Journal
CLINICAL MICROBIOLOGY AND INFECTION
Volume 13, Issue 12, Pages 1141-1143Publisher
WILEY-BLACKWELL
DOI: 10.1111/j.1469-0691.2007.01829.x
Keywords
antimicrobial resistance; dysentery; fluoroquinolones; resistance; shigellosis; treatment
Categories
Ask authors/readers for more resources
Shigellosis is a major cause of diarrhoea-related morbidity and mortality, especially in developing countries. Effective antibiotic treatment reduces the average duration of illness by reducing faecal excretion of the bacterium and preventing further transmission and potentially lethal complications. Treatment of shigellosis is currently limited by the high prevalence of multidrug-resistant strains of Shigella. Although fluoroquinolones are currently effective in treating adults, resistance to fluoroquinolones among Shigella spp. is emerging, and their use in children is subject to limitations. Azithromycin and third-generation cephalosporins are also effective in the treatment of shigellosis, but monitoring of Shigella isolates to detect the emergence of resistance is essential.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available